Publications by authors named "Paul Neeson"

62Publications

Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of Lu-PSMA-617 Prior to Prostatectomy.

Eur Urol Focus 2020 Nov 7. Epub 2020 Nov 7.

Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address:

View Article and Find Full Text PDF
November 2020

PVRIG is a novel NK cell immune checkpoint receptor in acute myeloid leukemia.

Haematologica 2020 Nov 5;Online ahead of print. Epub 2020 Nov 5.

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne.

View Article and Find Full Text PDF
November 2020

Challenges of PD-L1 testing in non-small cell lung cancer and beyond.

J Thorac Dis 2020 Aug;12(8):4541-4548

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

View Article and Find Full Text PDF
August 2020

IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors.

Mol Ther 2020 11 21;28(11):2379-2393. Epub 2020 Jul 21.

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. Electronic address:

View Article and Find Full Text PDF
November 2020

TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.

Cancers (Basel) 2020 Jun 11;12(6). Epub 2020 Jun 11.

Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.

View Article and Find Full Text PDF
June 2020

Immune profiling of pediatric solid tumors.

J Clin Invest 2020 Jul;130(7):3391-3402

Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF
July 2020

P53: A Guardian of Immunity Becomes Its Saboteur through Mutation.

Int J Mol Sci 2020 May 13;21(10). Epub 2020 May 13.

Tumour Suppression Laboratory, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.

View Article and Find Full Text PDF
May 2020

Tissue-resident memory T cells in breast cancer control and immunotherapy responses.

Nat Rev Clin Oncol 2020 06 28;17(6):341-348. Epub 2020 Feb 28.

Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF
June 2020

Validation and characterisation of prognostically significant PD-L1 immune cells in HPV+ oropharyngeal squamous cell carcinoma.

Oral Oncol 2020 02 12;101:104516. Epub 2019 Dec 12.

Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address:

View Article and Find Full Text PDF
February 2020

A Distinct Pretreatment Immune Gene Signature in Lentigo Maligna Is Associated with Imiquimod Response.

J Invest Dermatol 2020 04 30;140(4):869-877.e16. Epub 2019 Sep 30.

Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF
April 2020

IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma.

Expert Opin Investig Drugs 2018 Aug 17;27(8):691-697. Epub 2018 Jul 17.

a Department of Haematology , Peter MacCallum Cancer Centre , Melbourne , Victoria , Australia.

View Article and Find Full Text PDF
August 2018